Pfizer - Development of a Well Sustained Patient Improvement Apparatus - Essay Example

Technological Technological During the period of 1999 Pfizer has introduced its new discovery of a research centre which is d as the Discovery Technology Centre and this institution is located in the region of Cambridge, Massachusetts (Pfizer.com (a), 2014). With this new institution the company aims at achieving higher level of efficiency and producing innovative advancements in the area of drug formulation. In this institution the company has made use of the increasing knowledge regarding the subject of gene families and with this new knowledge they are continuously involved in the process of developing new and improved models in order to make new drugs related discoveries. The company is in a continuous process of investing in the area of healthcare in order to advance the health and wellbeing of the members of the society. In order to meet its mission of advancing health and wellbeing, during the period of 2000 the company opened one of the largest structures throughout the globe and this structure is devoted towards making discovery of new and improved drugs that will be assistive in advancing the health and wellbeing of both animals as well as human beings. This structure is located in the region of Groton, Connecticut where the organization is already operating a highly efficient research comp. With the introduction of this building the company has become one of the first drug development companies to invest more than $4 billion and aims and continuing to increase its investments to develop better products (Pfizer.com(a), 2014). Development Of A Well Sustained Patient Improvement Apparatus Pfizer’s main aim and objective throughout the course of its existence has been to be involved in the process of continuous improvement in order to develop various therapies that can be helpful in improving the health of patients throughout the world. The company believes that it can only achieve its objectives if it is continuously involved in the process of research and development. They believe that with the help of research and development, the company can identify and then transform up-to-date technological and scientific advancements into remedies that can be of immense importance to patients suffering throughout the world. The president of the company, Mikael Dolsten, who is the president of the company’s Worldwide Research and Development area, believes that the company has experienced a novel situation in the area of innovating biomedicine (Dolsten, 2014). It has been almost over a period of ten years since the human genome experimentation and decoding started taking place and now the organization has developed a higher level understanding of the various causes of diseases amongst human beings and the way human biology operates. The president believes that in order to develop and deliver new remedies for diseases it is not enough to depend on great science and the company had to move a one step forward to achieve its purpose. The president states that the company has worked hard and while making betterments to its research and development the company had to concentrate on their old method of research and development. The company has been successful in integrating the field of science as well as business together and this has resulted in alteration of the way they were doing business. Now they have taken quite a collaborative approach and they are more focused than ever before and have become a huge power for their patients. Through this hard word and reengineering the company has been able to develop an engine that has the ability of delivering patients with a well sustained flow of significant new drugs as well as remedies each year. The company is highly focused towards its main competencies that the organization perceives as their best abilities to deliver novel products suiting the needs of the patients. Biosimilars The term Biosimilars is even used to refer to follow-on biologics that are products that fall in the category of biologic medicine. These products are developed with the assistance of organisms that are alive. These products are even developed with the help of live drug materials that have been obtained from live organisms through the method of recombinant DNA or other methods that all in the category of controlling gene expressions. These products have been approved by the drug administrators and are developed through continuous analysis that is conducted with the help of tests that are both clinical as well as nonclinical in nature. These tests are conducted to exhibit that these products are quite similar in functionality, security as well as makeup as compared to their reference. The company Pfizer has built on its existence experience in the field of biologics and has even used its strengths in the area of development, marketing and regulation in order to develop biosimiliars that are of higher quality and safe for use. The development of these biosimiliars has provided both the patients as well as the physicians with new and improved methods of treating diseases. The company has an experience of more than thirty years in the area of developing products through recombinant DNA and they have been able to develop novice products to deliver to several healing areas and the organization is well equipped to match the increasing demand for higher quality biosimilar products (Pfizer.com (b), 2014). Biological Medicines The term biologic is used to refer to product comprising of large molecules used for medical purposes and this product is developed through existing organisms that consist of proteins found in cells that are alive. It is quite difficult to develop biologics because of their size as compared to the small size of traditional molecule drugs. The organization that is responsible for approving these products is FDA and they have developed a novel process of approving these products. These products now offer new methods of treating patients that are suffering from deadly diseases. These products can be used in the region of diabetes, hereditary issues, immunology and others. During the period of 2008, the company started a new website that helps professionals of the field of medicine to make decisions that are backed with accurate information. The company has even started a unit that is recognized as Global Regenerative Medicine Unit and the purpose of this unit is to conduct research and development in the area of stem cell research to develop new methods of treating individuals suffering from organ issues (Pfizer.com(a), 2014). References Dolsten, M. (2014). R&D Vision | Pfizer: One of the world’s premiere biopharmaceutical companies. [online] Pfizer.com. Available at: http://www.pfizer.com/research/science_and_technology/rd_vision [Accessed 26 Oct. 2014]. Pfizer.com (b), (2014). Biosimilars | Pfizer: One of the world’s premiere biopharmaceutical companies. [online] Available at: http://www.pfizer.com/research/science_and_technology/biosimilars [Accessed 26 Oct. 2014]. Pfizer.com(a), (2014). Company history | Pfizer: One of the world’s premiere biopharmaceutical companies. [online] Available at: http://www.pfizer.com/about/history/all [Accessed 26 Oct. 2014]. Read More